Our mission

We aim to reduce the burden of disease and economic impact of dementia on patients, caregivers and society. 


Goals

See some of the most important goals for this research program.

read more

Goals

  • To lay foundations for a 0% growth in the worldwide incidence of PD. 
  • To contribute to development of the first disease-modifying strategy to slow down disease progression, either in the preclinical or clinical stage for PD and specific other movement disorders. 
  • To generate new insights into the pathophysiology of movement disorders. 
  • To develop innovative biomarkers. 
  • To leverage AI-driven tools. 
  • To develop innovative treatments in both the symptomatic and disease-modifying domains. 
  • To improve quality of life, clinical outcomes and public health policies/clinical practices.  


Research groups contributing to this research program


Spokesperson

dr. Jurgen Claassen MD, PhD

contact form

Spokesperson

prof. dr. Edo Richard

contact form